Lancet Market to Perceive Momentous Accruals with a hefty CAGR By 2024

 The Global Lancet Market Registered a CAGR of 10.50% during the assessment period, with a market value of USD 1,595.5 Million in 2018.

Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. The factors driving the market growth include growing incidence rate of contagious and non-contagious diseases, increasing prevalence of diabetes, and rising inclination towards home care and home diagnostics. However, the risk associated with blood transfusion is expected to hinder the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2078 

Market Dynamics

One of the major applications or functioning areas of lancets is to monitor diabetes in the diabetic population. According to the Centers for Disease Control and Prevention (CDC), 9.4% of the US population are diabetic patients. With the increasing prevalence of diabetes, the demand for lancets is expected to be enormous, thus resulting in the increasing demand for devices and products to monitor and control diabetes, eventually leading to increased use of lancets.

Segmentation

The global lancet market based on type has been segmented into safety lancet and personal lancet. Safety lancets can be further divided into push-button safety lancets; pressure activated safety lancets and side button safety lancets. Based on end user, the market is segmented into the hospitals & clinics, diagnostic centers & pathology laboratories, home diagnostics, research and academic laboratories, and others. The hospitals & clinics segment held a major share with a market value of USD 544 Million in 2018.

Key Players

The prominent players in the global lancet market are Terumo Corporation (Japan), Bayer AG (Germany), HTL-STREFA S.A. (Poland), Sarstedt AG & Co. (Germany), Becton, Dickinson and Company (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Greiner Bio-One International GmbH (US), Improve Medical Instruments Co. Ltd (US) and others.

Some of the key strategies followed by players operating in the global lancet market were innovation, product development, acquisition, and mergers.

Regional Analysis

The global lancet market, based on region, is divided into Europe, the Americas, Asia-Pacific, and the Middle East and Africa.

Europe held the largest share of the global lancet market. The Europe market demonstrated substantial growth in the market due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers, etc. and the growth in insulin users. The Americas held a substantial share in the global lancet market owing to the rise in the prevalence of diabetes and the increasing need for a diabetes diagnosis. Asia-Pacific was the fastest growing region in the global market and accounted for 19.1% market share in the global market in 2018. The growth in this region is attributed to the low manufacturing cost and low labor cost in the region. Moreover, the Middle East and Africa showed the least growth owing to low per capita income and lack of adequate healthcare spending.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/lancet-market-2078

Radiology Services Market – A market with high CAGR and return on investment by 2024

 Market Scenario

The global radiology services market accounted for USD 8,102.51 million in 2018 and is expected to register a CAGR of 10.5% during the forecast period (2019–2024).

Radiology is the technology that diagnosis and treat diseases within the human body by using medical imaging. The radiology services are served by the radiologists and experts that are qualified for performing the test and have unique postgraduate medical education in, radiation effects on the human body, radiation safety/protection, appropriate performance and interpretation of quality radiologic, and medical imaging examinations. Radiology services comprise X-Rays, computed tomography (CT), ultrasound, fusion imaging, positron emission tomography (PET), nuclear medicine, and magnetic resonance imaging (MRI). These imaging techniques should be performed after having adequate training and understanding of radiation safety and protection.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7904

The rising prevalence of the chronic disease, increasing healthcare expenditure, the emergence of thin client 3D viewers, advancement in radiology technology, rising demand for minimally invasive procedures are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, In June 2018, FDA has anticipated reclassifying some types of radiology image software analyzers from class III to class II devices for mammography breast cancer, ultrasound breast lesions, and radiograph lung nodules. This will help to reduce the regulatory burden on the medical device industry.

However, the risk of high radiation exposure associated with the devices may hamper the growth of the market during the assessment period.

Segmentation

The global radiology services market has been segmented on the basis of product type, application, technology, end user, and region.

On the basis of product type, the market has been classified as stationary digital radiology systems and portable digital radiology systems. Stationary digital radiology systems have been further segmented into stationary ceiling-mounted systems and floor-to-ceiling mounted system. Based on application, the market has been segmented into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others. The market, by technology, has been segmented into computed radiology and direct digital radiology. On the basis of end user, the market has been classified as hospitals, diagnostic centers, and others. The stationary digital radiology segment is expected to hold the largest market share of the radiology services market due to acceptance of stationary systems in hospitals, extensive application, and less exposure to radiation. However, portable digital radiology segment is showing the highest growth rate owing to simplicity in the workflow, low-cost, and proficiency performing complex computational tasks.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The radiology services market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European radiology services market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The radiology services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The radiology services market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Some of the key players in the global radiology services market are 4ways Healthcare Limited, Cybernet Medical Corporation, Everlight Radiology, Global Diagnostics, Medica Reporting Ltd., Onrad, Inc, Radisphere National Radiology Group Inc., RamSoft Inc., Siemens Healthcare, Telediagnostics Services Pvt. Ltd., Telemedicine Clinic, Teleradiology Solutions Inc, and Virtual Radiology (vRAD).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/radiology-services-market-7904

Flat Panel Detector Market to Witness Widespread Expansion During 2020 to 2024

 Market Highlights

The global flat panel detector (FPD) market held a market value of USD 3.06 Billion in 2018 and is projected to grow at a CAGR of 6.7% over the forecast period.  

Flat panel detector (FPD) is a type of solid-state X-ray digital radiography device. It works in the same way as image sensors used in digital photography and video works. Growing public and private investments in digital imaging technologies and declining prices and benefits offered by digital detectors are positively affecting market growth. Additionally, growing medical tourism in developing countries is also expected to drive the market growth.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7903 

On the other hand, the high cost of the system is likely to hamper the growth of the market.

Segmentation

The global flat panel detector (FPD) market has been segmented by portability, application, and end user.

By portability, the market has been segmented into fixed and portable. The portable flat panel detector is expected to show the largest market share.

By application, the market has been segmented into medical, orthopedic, cardiac, veterinary, mammogram, dental, and others.

The market, by end user, has been segmented into hospitals and clinics, and diagnostic centers.

Key Players

Some of the prominent players in the global flat panel detector (FPD) market are General Electric Company, Carestream Health, Canon Medical Systems Corporation, Fujifilm Holdings America Corporation, PerkinElmer Inc., Trixell, iRay Technology, Varian Medical Systems, Inc., Agfa-Gevaert Group, New Medical Imaging Co., Ltd, Varex Imaging Corporation, Imaging Dynamics Company Ltd and others.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global flat panel detector (FPD) market owing to the technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases in the region has fueled the growth of the market. Additionally, major companies are located in North America which is fueling the market growth.

Europe is expected to hold the second largest position in the global flat panel detector (FPD) market owing to the presence of well-developed healthcare sector, strong government support for research & development and high healthcare expenditure in the European countries. Well-developed technologies in Europe have also played a predominant role in the development of the European market.

Asia-Pacific is anticipated to be the fastest growing region in the global flat panel detector (FPD) market owing to the growing adoption of digital imaging systems, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.

The Middle East & Africa has the least share of the global flat panel detector (FPD) market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/flat-panel-detector-market-7903

Feminine Hygiene Market Poised to Witness a Significant Growth by 2024

 Market Highlights

The global feminine hygiene market was valued at USD 21.96 Billion in 2018. The market is projected to register a CAGR of 7.2 % during the forecast period of 2019 to 2024.

Numerous factors, such as the rising disposable income of the middle class in emerging countries such as Brazil and China, and the emergence of low-cost feminine hygiene products. Moreover, the increasing awareness of female health and hygiene is anticipated to boost the market growth over the assessment period. Furthermore, the growing demand for products such as tampons and panty liners in developing countries is anticipated to propel the growth of the market during the forecast period. However, the increasing number of product recalls due to several factors such as the growing allergy cases among women and the presence of toxic chemicals in feminine products are anticipated to hinder the growth of the global feminine hygiene market

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7986 

Segmentation

The global feminine hygiene market, based on product type, has been segmented into sanitary napkins/pads, tampons, panty liners, menstrual cups, and feminine hygiene wash. The sanitary napkins/pads segment is anticipated to hold the largest market share as they have a high adoption rate among women across all geographic regions. The market, by distribution channel, has been segmented into supermarket and department stores, retail pharmacies, online retail stores, and others. Supermarkets and department stores segment are expected to hold the major share as a majority of women tend to purchase sanitary items along with household items.

Key Players

Some of the key players in the global feminine hygiene market are Johnson & Johnson, Procter and Gamble, Edgewell Personal Care, Unicharm Corporation, Ontex International, Svenska Cellulosa Aktiebolaget SCA, Kimberly-Clark Corporation, Lil-Lets Group Ltd, Natracare LLC, and Kao Corporation.

Regional Analysis

Geographically, Asia-Pacific region is anticipated to dominate the global feminine hygiene market due to various factors such as the rising disposable income of the middle-class population, especially in countries such as China and India which has led to rising in women’s buying quality hygiene products. Additionally, the growing awareness about feminine hygiene products owing to several initiatives taken by the government and the non-government organization in this region is anticipated to boost the market growth.

Americas is expected to hold a second market position in the global feminine hygiene market. The market growth in the region is attributed to the high penetration of high-end products such as tampons, panty liners, and internal cleansers, an increasing number of working women, and growing demand by women for organic and biodegradable products.

Europe is likely to show a significant amount of growth in the global feminine hygiene market. The market growth in the region is owing to factors such as easy access to feminine hygiene products, rapid urbanization, growing disposable income, and increasing spending on menstrual products. As per the data published by the Bloody Good Period, in 2018, the average lifetime spends on period products by women adds up to around USD 5,380.56 in the UK. The Middle East & Africa is expected to account for the lowest share of the global market due to low disposable incomes and limited awareness about menstrual hygiene in the region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/feminine-hygiene-market-7986 

Global Digital Radiology Devices Market to Significant Growth Foreseen by 2024

 Market Highlights

Global digital radiology devices market expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 8146.54 million in 2018 and is projected to grow at a CAGR of 10.8% over the forecast period.

The global digital radiology devices market is growing at a rapid pace, the major factors influencing the growth of the market include; increasing geriatric population, increasing prevalence of chronic and dental diseases. Cardiovascular imaging, chest imaging, and dental imaging have been few of the major application of digital radiology device.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7973 

Chronic diseases and conditions are increasing rapidly worldwide. According to the World Health Organization (WHO), the amount of the burden of chronic diseases is expected to increase to 60% by 2020, and 79% of deaths due to these diseases would occur in developing countries. This increasing chronic disease is influencing the growth of the market.

Moreover, dental imaging has also been one of the fastest growing segments for digital radiology market. Dental Imaging and digital radiology have been a preferred imaging methodology for comprehensive orthodontic treatment all around the globe. The data acquired from digital radiology imaging provides numerous substantial advantages in orthodontic procedures. For instance, digital radiology device gives precise measurements, enhances localization of impacted teeth, gives a visualization of airway abnormalities, it recognizes and measures asymmetry, it can be utilized to survey periodontal structures, to distinguish endodontic issues and various others. This increasing popularity of digital radiology devices in the field of orthodontics is further influencing the growth of the global digital radiology devices market.

Segmentation

The global digital radiology devices market has been segmented into type, method, application, and end user.

Based on type, market segmented into stationary digital radiology systems, (Ceiling-mounted systems, Floor-to-ceiling mounted systems) and portable digital radiology systems (Handheld radiology systems, Mobile radiology systems)

On the basis of method, the market is segmented into computed radiography (CR) and direct radiography (DR)

Based on application, the digital radiology devices market is segmented into cardiovascular imaging, chest imaging, dental imaging, mammography imaging, orthopedic imaging, and others.

Based on end user, the digital radiology devices market is segmented into hospitals & clinics, Diagnostic centers, and others.

Key Players

Some of the major players operating in the global digital radiology devices market are Fujifilm Holdings Corporation, Agfa-Gevaert Group, Canon Inc, Carestream Health Inc, Koninklijke Philips N.V., Siemens, Varian Medical Systems, Inc, Shimadzu Corporation, Hologic, Nucleotech Medical Systems International Limited, Protec GmbH & Co. KG, General Electric Company, Hitachi, Ltd., Konica Minolta, Inc,

Regional Analysis

Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Geographically, the Americas is anticipated to dominate the global digital radiology devices market owing to the presence of the major manufacturers, huge patient population, high healthcare expenditure, increasing adoption of technologically advanced devices. Europe is expected to hold the second largest position in the global digital radiology devices market. Asia-Pacific is the fastest growing digital radiology device market owing to the increasing need for better imaging devices, rapidly improving technology and the presence of a huge patient pool. The Middle East and Africa market for digital radiology device is expected to grow at a steady.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/digital-radiology-devices-market-7973

CAR T Cell Therapy Market to Witness Widespread Expansion During 2020 to 2025

  CAR T Cell Therapy Market Analysis

The CAR T cell therapy market size is predicted to touch USD 8716.06 million at a 58.52% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. CAR T cell therapy is amid the biggest breakthroughs and most promising treatment for cancer patients after chemotherapy. It is a form of immunotherapy where physicians gather immune cells from the patient, modify the same in the laboratory, and offer them the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. These infused cells multiply and remain in the patient’s body as living drugs. Short treatment time is one of the key benefits of CAR T cell therapy. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8102  

Numerous factors are adding to the CAR T cell therapy market demand. Such factors, as revealed by the latest MRFR report, include an increasing number of cell therapy clinical studies, growing pharmaceutical industry, technological advances for reliable and advanced treatment for cancer, and rising incidence of cancer both in adults & children worldwide. Additional factors adding to the CAR T cell therapy market growth include increasing initiatives by the government to promote cell therapy research in cancer and improve health care infrastructure and increasing approvals of CAR T cell therapies. 

On the contrary, high treatment costs and certain side effects that may cause CRS (cytokine release syndrome) and other forms of neurological problems, including delirium, hallucinations, coma, and seizures, are factors that may limit the CAR T cell therapy market growth over the forecast period. 

Market Segmentation

The Market Research Future’s CAR T cell therapy market report provides an inclusive segmental analysis of the CAR T cell therapy market on the basis of target antigen and application.

By target antigen, the CAR T cell therapy market has been segmented into CD22, CD19, & others. Among these, the CD19 target antigen segment will lead the market over the forecast period. It was valued USD 342.56 million in 2018. 

By application, the CAR T cell therapy market is segmented into diffuse large B-cell lymphoma, acute lymphoblastic leukemia, and others. Of these, diffuse large B-cell lymphoma will have a major share in the market over the forecast period. 

Regional Analysis 

By region, the global CAR T cell therapy market covers the growth opportunities and recent trends across Europe, the US, China, and the Rest of the World. Of these, the US will dominate the market over the forecast period for the rapid development along with the launch of novel therapies by top industry players to treat cancer, and huge patient pool suffering from cancer. 

The CAR T cell therapy market in Europe is predicted to hold the second-largest share over the forecast period for extensive research & rising investment to develop cancer therapies, and rising prevalence of hematologic cancer especially multiple myeloma, lymphoma, and leukemia. 

The CAR T cell therapy market in China is predicted to have significant growth over the forecast period for the increasing disposable income and developing healthcare infrastructure. Besides, the rising number of CAR T cell therapy market companies signing and collaborating research and manufacturing contracts with the region’s local players for these therapies are also adding market growth. Cesca Therapeutics, for instance, signed an agreement in March 2018 with Boyalife Group in China for CAR-T cell-related manufacturing outsourcing, development, and bioprocessing. 

The CAR T cell therapy market in the RoW is predicted to have stable growth over the forecast period.

Key Players

Eminent players profiled in the CAR T cell therapy market report include Mustang Bio (US), Sorrento Therapeutics (US), Legend Biotech (US), Juno Therapeutics (US), Autolus Therapeutics PLC (UK), CARsgen Therapeutics (China), Cellectis (France), Pfizer, Inc. (US), Kite Pharma (US), and Novartis AG (Switzerland).

Industry News

March 2020: Tessa Therapeutics’ CD30-targeted CAR T-cell therapy has received RMAT designation by US FDA to treat refractory or relapsed classical Hodgkins lymphoma. Its benefits comprise early detections together with sponsors. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/car-t-cell-therapy-market-8102  

Global Theranostics Market to Record an Exponential CAGR by 2025

 Market Highlights

The global theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% over the forecast period. Theranostics is a new field of medicine which combines therapeutics, nanoscience, and diagnostics based on specific targeted diagnostic tests. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized medicine technology. Theranostics is a proposed diagnostic methodology for personalizing therapeutic intervention and the integration of imaging and therapy in a single system, enabling simultaneous therapy and follow-up of the treatment. Some of the market growth factors are increasing development of novel companion diagnostic tests, emerging use of theranostics, increasing partnerships and collaborations by major market players to develop innovative companion diagnostics, and rising burden of chronic diseases. In contrast, lack of proper defined regulations for theranostics tests and inadequate reimbursement facilities in most of the countries are anticipated to impede the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8057 

Molecular theranostics is a major field which includes small biochemical moieties and biomacromolecules. Theranostics is important for personalized as well as precision medicine that provides therapeutic outcome so that a physician can make a decision pertaining to the course of treatment for the patient.

Segmentation

The global theranostics market has been segmented into the therapeutic area, technology, end user, and region.

By therapeutic area, the market has been segmented into oncology, cardiovascular diseases, neurological disorders, immunological disorders, and others. The oncology segment is further categorized into breast cancer, colorectal cancer, lung cancer, cervical cancer, and others.

On the basis of technology, the market has been divided into polymerase chain reaction (PCR), immunohistochemistry (IHC), in situ hybridization (ISH), sequencing, and others. The sequencing segment is likely to register comparatively higher CAGR over the forecast period due to the increasing number of proof-of-concept case studies and research related to sequencing, particularly next-generation sequencing (NGS) technology.

Based on end user, the market has been classified into hospitals and clinics, diagnostic laboratories, and others.

Key Players

Few of the prominent players in the global theranostics market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Focus Diagnostics, Abbott Laboratories, Illumina, Inc., Agilent Technologies, Inc., QIAGEN, Myriad Genetics, Inc., Foundation Medicine, Inc., and AmeriPath, Inc.

Regional Analysis

The global theranostics market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On a regional basis, the Americas would command the market throughout the forecast period attributed to the domicile of major market participants, increasing research and development activities, and growing adoption of theranostics in the US and Canada. For instance, in June 2018, Genome Canada launched a national initiative for clinical implementation of precision health that would ultimately impact the market growth in the near future.

Europe would follow Americas in terms of value over the forecast period due to flourishing pharmaceutical and medical device companies, increasing partnerships and collaborations between life science companies and medical diagnostics companies, and growing personalized medicine sector. Personalized medicine (PM) is an emerging approach to prevention, diagnosis, treatment, and care which is assisting in addressing the challenge of the aging of the population, rising prevalence of chronic diseases, and increasing healthcare costs.

The market in Asia-Pacific would register the fastest market growth over next seven years owing to booming medical tourism, swiftly developing healthcare infrastructure, and growing awareness in the developing countries, namely, India, China, Singapore, and Australia.

The Middle East & Africa has the least share of the global theranostics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/theranostics-market-8057